`Interesting' Juxtaposition

In his article, Hubel pointed out the ties between the terrorist Animal Liberation Front and the above-ground People for the Ethical Treatment of Animals. A January 1992 publication of the Office of Technology Assessment (Technology Against Terrorism: Structuring Security) links these groups with Barnard's own organization, the Physicians Committee for Responsible Medicine, whose views, the OTA report notes, appear "to have little s

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In his article, Hubel pointed out the ties between the terrorist Animal Liberation Front and the above-ground People for the Ethical Treatment of Animals. A January 1992 publication of the Office of Technology Assessment (Technology Against Terrorism: Structuring Security) links these groups with Barnard's own organization, the Physicians Committee for Responsible Medicine, whose views, the OTA report notes, appear "to have little support within the medical community" (page 27). Some of Barnard's comments clearly illustrate why this should be the case.

For example, Barnard makes the unsubstantiated claim that more than half the drugs marketed from 1976 through 1985 "were so much more toxic than premarket animal and limited human trials had indicated that they had to be relabeled or withdrawn." I am not certain how serious a problem "relabeling" is, but according to the Office of Planning and Evaluation (OPE) of the United States Food and Drug Administration, only ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Sharon Russell

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide